Cylerity Corporation

Based in the US, Cylerity Corporation provides innovative financial technology solutions tailored to healthcare providers, enhancing cash flow management through advanced funding against insurance claims. Cylerity Corporation, founded in 2019, specializes in financial technology solutions for healthcare providers. The company has demonstrated its adaptability by successfully navigating two funding deals. Operating from its headquarters in the United States, Cylerity has raised a total of USD 4.

00 mn, primarily through its most recent Seed round led by HealthX Ventures and involving multiple investors, including C2 Ventures and Wisconsin Investment Partners. The company was founded by a group of entrepreneurs with prior experience in the fintech industry, focusing on delivering effective solutions for healthcare finance. Cylerity specializes in innovative financial technology solutions designed specifically for healthcare providers, offering a platform that accelerates cash flow by advancing funds against insurance claims. The core product facilitates advances of 70-90% of claims submitted to Medicare and commercial insurance within 48 hours, enabling healthcare organizations to stabilize their cash flow and better manage operational expenses without impacting existing staff operations or technology.

The platform employs a proprietary valuation algorithm that accurately predicts expected reimbursements and assesses the risk associated with claims based on third-party payers’ credit ratings. Cylerity serves a diverse client base, including rural hospitals and rehabilitation centers, primarily within the United States, facing challenges related to slow payment cycles from payers. Through its solutions, Cylerity aims to address the financial challenges faced by healthcare providers, particularly in rural and critical access environments. Revenue generation for Cylerity is structured around the advances provided to healthcare organizations against their accounts receivable.

The company engages in B2B transactions, where healthcare providers utilize the Cylerity platform to access financial resources more efficiently. Clients submit insurance claims through the platform, and upon approval, Cylerity facilitates immediate access to cash against these receivables, thereby enhancing liquidity for the providers. The financial model includes transaction fees associated with the advances, allowing for a revenue stream linked directly to the volume and value of claims processed. Cylerity's flagship service revolves around its cash acceleration capabilities, which are essential for healthcare organizations grappling with delayed reimbursements, thereby creating a compelling case for adoption among its target clientele.

In October 2025, Cylerity Corporation raised USD 4. 00 mn in Seed funding, led by new investor HealthX Ventures, with participation from C2 Ventures, Upstream Ventures, Wisconsin Investment Partners, and Tundra Angels. The funding will be used to enhance its AI-driven platform, which aims to improve the speed and accuracy of reimbursement predictions for healthcare providers. Cylerity is also planning to expand its reach into additional geographic markets, particularly targeting underserved areas where healthcare finance solutions are critical.

This expansion is aligned with their strategy to address cash flow issues faced by healthcare organizations operating in regions with complex payer environments.